All Stories

  1. Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital
  2. Potential Impact of a Microarray-Based Nucleic Acid Assay for Rapid Detection of Gram-Negative Bacteria and Resistance Markers in Positive Blood Cultures
  3. Epitope Mapping by Epitope Excision, Hydrogen/Deuterium Exchange, and Peptide-Panning Techniques Combined with In Silico Analysis
  4. Risks of “Blind” Automated Identification Systems in Medical Microbiology
  5. Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine
  6. Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome
  7. Comparative Evaluation of the Bruker Biotyper and Vitek MS Matrix-Assisted Laser Desorption Ionization-Time Of Flight (MALDI-TOF) Mass Spectrometry Systems for Identification of Yeasts of Medical Importance
  8. Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools
  9. Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation
  10. A closer look at prion strains
  11. Possible Future Monoclonal Antibody (mAb)-Based Therapy against Arbovirus Infections
  12. Structural and Antigenic Definition of Hepatitis C Virus E2 Glycoprotein Epitopes Targeted by Monoclonal Antibodies
  13. JC Polyomavirus (JCV) and Monoclonal Antibodies: Friends or Potential Foes?
  14. Broadly neutralizing human monoclonal antibodies: a novel resource against influenza viruses
  15. Broadly anti-hepatitis C virus (HCV) cross-neutralizing monoclonal antibodies (mAbs) directed against the HCV/E2 glycoprotein and not subjected to Ab-mediated interference
  16. Influenza B-Cells Protective Epitope Characterization: A Passkey for the Rational Design of New Broad-Range Anti-Influenza Vaccines
  17. Molecular Signatures of Hepatitis C Virus (HCV)-Induced Type II Mixed Cryoglobulinemia (MCII)
  18. Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interference
  19. Neutralization Interfering Antibodies: A “Novel” Example of Humoral Immune Dysfunction Facilitating Viral Escape?
  20. Phage Display-based Strategies for Cloning and Optimization of Monoclonal Antibodies Directed against Human Pathogens
  21. Potential role of the detection of enterobacterial DNA in blood for the management of neonatal necrotizing enterocolitis
  22. A Non-VH1-69 Heterosubtypic Neutralizing Human Monoclonal Antibody Protects Mice against H1N1 and H5N1 Viruses
  23. HCV Proteins and Immunoglobulin Variable Gene (IgV) Subfamilies in HCV-Induced Type II Mixed Cryoglobulinemia: A Concurrent Pathogenetic Role
  24. A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes
  25. A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza
  26. Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV)
  27. The Era of Molecular and Other Non-Culture-Based Methods in Diagnosis of Sepsis
  28. Hepatitis C Virus (HCV) Infection May Elicit Neutralizing Antibodies Targeting Epitopes Conserved in All Viral Genotypes
  29. Antigen-Driven Evolution of B Lymphocytes in Coronary Atherosclerotic Plaques
  30. Molecular Diagnosis of Polymicrobial Sepsis
  31. Anti-HIV-1 Response Elicited in Rabbits by Anti-Idiotype Monoclonal Antibodies Mimicking the CD4-Binding Site
  32. Perspectives for the utilization of neutralizing human monoclonal antibodies as anti-HCV drugs
  33. Hepatitis C virus (HCV)-driven stimulation of subfamily-restricted natural IgM antibodies in mixed cryoglobulinemia
  34. Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies
  35. Identification of a Broadly Cross-Reacting and Neutralizing Human Monoclonal Antibody Directed against the Hepatitis C Virus E2 Protein
  36. Rapid molecular identification of fungal pathogens in corneal samples from suspected keratomycosis cases
  37. Modulation of epitope‐specific anti‐hepatitis C virus E2 (anti‐HCV/E2) antibodies by anti‐viral treatment
  38. Quantitation of Bacillus clausii in biological samples by real-time polymerase chain reaction
  39. Cloning and molecular characterization of a human recombinant IgG Fab binding to the Tat protein of human immunodeficiency virus type 1 (HIV-1) derived from the repertoire of a seronegative patient
  40. Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection
  41. Coronaviridae and SARS-associated Coronavirus Strain HSR1
  42. Diverging Effects of Human Recombinant Anti-Hepatitis C Virus (HCV) Antibody Fragments Derived from a Single Patient on the Infectivity of a Vesicular Stomatitis Virus/HCV Pseudotype
  43. Definition of biological activity and quantitation of different families of human anti-HCV/E2 antibodies by generation of human recombinant anti-E2 monoclonal Fab by phage display combinatorial repertoire library
  44. Mapping B-Cell Epitopes of Hepatitis C Virus E2 Glycoprotein Using Human Monoclonal Antibodies from Phage Display Libraries
  45. Nonneutralizing Human Antibody Fragments against Hepatitis C Virus E2 Glycoprotein Modulate Neutralization of Binding Activity of Human Recombinant Fabs
  46. Characterization of four major human B-cell epitopes on the surface of HCV E2 glycoprotein by generation of human monoclonal fab from phage display antibody librariesis
  47. Molecular dissection of the human humoral response against HCV E2 glycoprotein by cloning of the antibody repertoire in phage display combinatorial vectors
  48. Characterization of four major human B-cell epitopes on the surface of HCV E2 glycoprotein by generation of human monoclonal fab from phage display antibody librariesis
  49. Dissection of the anti-transglutaminase IgA1 local response by construction of phage-displayed combinatorial libraries from gastro-jejunal biopsies of patients with celiac disease
  50. Dissection of the IgA1 local response by construction of isotype-specific combinatorial libraries displayed on the surface of phage from gastrojejunal biopsies
  51. Molecular study and epitope mapping of the human antibody response against HCV/E2 glycoprotein by generation of monoclonal recombinant Fabs